News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
FDA Cites Problems With CryoCor, Inc. Device
June 25, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Federal regulators said Monday a Cryocor Corp. device that uses extreme cold to treat defective heart muscle did not show overwhelmingly safe or effective results in company studies. The company's shares dropped sharply.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
CDC
CDC Adopts ACIP Recommendations on Chickenpox, COVID-19 Vaccines
October 6, 2025
·
1 min read
·
Heather McKenzie
Regulatory
Fired NIAID Director Claims Ouster Was Payback for Whistleblower Report
October 3, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
CMS Finalizes Stronger Protections for Orphan Drugs Against IRA Price Negotiations
October 3, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Trump Delays Pharma Tariffs Yet Again
October 2, 2025
·
2 min read
·
Tristan Manalac
